Literature DB >> 33896835

Silencing circPVT1 enhances radiosensitivity in non-small cell lung cancer by sponging microRNA-1208.

Meifang Huang1,1, Tianqian Li1,1, Qing Wang1, Chongxin Li1, Huahua Zhou1, Shengyi Deng1, Zengbo Lv1, Yongmei He1, Bo Hou2, Guangying Zhu3,4,5.   

Abstract

BACKGROUND: Radiotherapy is one of main useful therapies in non-small cell lung cancer (NSCLC). Nevertheless, the underlying mechanism between NSCLC cell radiosensitivity and effective treatment remains unclear.
OBJECTIVE: The aim is to explore the relationship between circular (circ) RNA and NSCLC cell radiosensitivity.
METHODS: CircRNA plasmacytoma variant translocation 1 (PVT1) and microRNA (miR)-1208 expression in NSCLC cells were assessed using quantitative reverse transcriptase PCR (qRT-PCR). NSCLC cells were transfected with si-PVT1 or miR-1208 inhibitor and then exposed to irradiation. Cellular biology behaviors were detected using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Terminal deoxynucleotidyl transferase dUTP Nick-End Labeling (TUNEL), colony formation, invasion and western blot. Additionally, binding between circPVT1 and miR-1208 was testified by dual-luciferase reporter and RIP assay.
RESULTS: CircPVT1 was upregulated in NSCLC cells after irradiation treatment. Silencing circPVT1 induced inhibition of NSCLC cell growth and invasion, accompanied by cell apoptosis and γ-H2AX expression. Moreover, NSCLC cell proliferation and invasion was further inhibited by irradiation treatment in circPVT1-silenced cells, indicating a strong radiosensitivity of NSCLC cells. CircPVT1 functions as a competing endogenous RNA of miR-1208. Silencing miR-1208 reversed NSCLC cell sensitivity response to irradiation and activated PI3K/AKT/mTOR pathway in circPVT1-silenced cells.
CONCLUSIONS: Silencing circPVT1 enhanced radiosensitivity of NSCLC cells by sponging miR-1208.

Entities:  

Keywords:  NSCLC; PI3K/AKT/mTOR signaling; circPVT1; miR-1208; radiosensitivity

Mesh:

Substances:

Year:  2021        PMID: 33896835     DOI: 10.3233/CBM-203252

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  6 in total

Review 1.  CircPVT1: a pivotal circular node intersecting Long Non-Coding-PVT1 and c-MYC oncogenic signals.

Authors:  Alina Catalina Palcau; Valeria Canu; Sara Donzelli; Sabrina Strano; Claudio Pulito; Giovanni Blandino
Journal:  Mol Cancer       Date:  2022-01-28       Impact factor: 27.401

2.  Circular RNA SOX13 promotes malignant behavior and cisplatin resistance in non-small cell lung cancer through targeting microRNA-3194-3p/microtubule-associated protein RP/EB family member 1.

Authors:  Libin Zhang; Hao Peng; Zheyuan Xu; Qiuju Yang; Yang Wang; Han Wang; Liang Bu
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

3.  CircRNA SOD2 motivates non-small cell lungs cancer advancement with EMT via acting as microRNA-2355-5p's competing endogenous RNA to mediate calmodulin regulated spectrin associated proteins-2.

Authors:  Changsheng Lv; Yiying Hu; Xin Zhou; Yuntao Zhu; Jin Wang; Fachen Zhou
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

Review 4.  CircRNAs in Malignant Tumor Radiation: The New Frontier as Radiotherapy Biomarkers.

Authors:  Xixi Wu; Junying Wu; Lingxia Wang; Wei Yang; Bo Wang; Huan Yang
Journal:  Front Oncol       Date:  2022-03-16       Impact factor: 6.244

5.  Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.

Authors:  Feiyun Chang; Jiali Li; Quan Sun; Shuqing Wei; Yongming Song
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 6.  Role of circular RNAs in the diagnosis, regulation of drug resistance and prognosis of lung cancer.

Authors:  Chengpeng Sang; Dingyu Rao; Caixia Wu; Yao Xia; Maoyan Si; Zhixian Tang
Journal:  Oncol Lett       Date:  2022-07-07       Impact factor: 3.111

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.